drugset / Trial / NCT05884463

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

NCT05884463

Completed 62 enrolled Zhejiang University
NaSingle-groupOpen-labelDiagnostic

Summary

To explore the potential efficacy of 18F-FAPI-04 PET/CT for PDAC tumour staging and compare the results with those obtained using 18F-FDG PET/CT.

Timeline

Start
2021-04-01
Primary completion
2023-02-28
Completion
2023-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FAPI Diagnostic / imaging agent Intravenous
Subject 18F-FDG Diagnostic / imaging agent Intravenous